Middle East and Asia Pacific Cell and Gene Therapy Market, By Therapy Type, By Indication, By Technology, By Geography

Description

Middle East And Asia Pacific Cell And Gene Therapy Market is estimated to be valued at USD 41.3 Bn in 2026 and is expected to reach USD 68.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 41.3 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	11.80%	2033 Value Projection:	USD 68.7 Bn

Cell therapy is the administration of living cells in patients for the treatment of a disease such as oncology, Immunology and others. The source of a cell can be autologous or allogeneic, which can be derived from stem cells such as bone marrow. Stem cells therapy is used in bone marrow transplantation. Gene therapy is the introduction, removal, or change in the patient's genetic code for the treatment of a disease. Moreover, it modifies the expression of an individual's genes or repairs abnormal genes. The therapy involves the administration of nucleic acid (DNA/RNA) with carriers called vectors.

Market Dynamics

Key players are focusing on product approvals and launches to strengthen their position in the Middle East and Asia Pacific cell and gene therapy market. For instance, in March 2021, Novartis received Singapore Health Sciences Authority (HSA) approval for Kymriah (tisagenlecleucel), as the first commercial chimeric antigen receptor T-cell (CAR-T) therapy in Singapore under the new cell, tissue, and gene therapy products (CTGTP) regulatory framework.

Furthermore, in February 2021, the commercial manufacturing of Novartis's Kymriah was approved by Therapeutic Goods Administration (TGA) in Australia.

Key features of the study

This report provides an in-depth analysis of the Middle East and Asia Pacific cell and gene therapy market, provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Middle East and Asia Pacific cell and gene therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Novartis International AG, Pfizer, Inc., Sanofi S.A., Amgen, Inc., Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche AG, Bluebird Bio, Inc. (Celgene Corporation), Gene biotherapeutics, Sibiono GeneTech Co. Ltd., Kolon TissueGene, Inc., Horama S.A., MeiraGTx Limited, Gilead Sciences, Inc., Biogen INC., Organogenesis, Inc., JCR Pharmaceuticals Co. Ltd, uniQure N.V., WuxiAppTec, Lonza, and Immuneel Therapeutics Pvt Ltd
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Middle East and Asia Pacific cell and gene therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Middle East and Asia Pacific cell and gene therapy market

Market Segmentation

By Therapy Type
- Cell Therapy
- Stem Cells
- T Cells
- Dendritic Cells
- NK Cells
- Gene Therapy
- Germline Gene Therapy
- Somatic Gene Therapy
By Indication
- Dermatology
- Musculoskeletal
- Oncology
- Immunology
- Cardiology & Neurology
- Others
By Technology
- Lentiviral Vector
- Plasmid DNA
- AAV
By Region
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Key Players Insights
- Novartis International AG
- Pfizer, Inc.
- Sanofi S.A.
- Amgen, Inc.
- Regeneron Pharmaceuticals, Inc.
- Hoffmann-La Roche AG
- Bluebird Bio, Inc. (Celgene Corporation)
- Gene biotherapeutics
- Sibiono GeneTech Co. Ltd.
- Kolon TissueGene, Inc.
- Horama S.A.
- MeiraGTx Limited
- Gilead Sciences, Inc.
- Biogen INC.
- Organogenesis, Inc.
- JCR Pharmaceuticals Co. Ltd
- uniQure N.V.
- WuxiAppTec
- Lonza
- Immuneel Therapeutics Pvt Ltd.

Product Code: CMI4981

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Therapy Type
- Market Snippet, By Indication
- Market Snippet, By Technology
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Drivers
Restraints
Challenges in Cell and Gene Therapy
Capital Intensive Process
Opportunity
Impact Analysis
Adoptive T-cell's Therapy Evolution
Market Trends
Regulatory Scenario
Reimbursement Scenario
Pipeline Analysis
Partnership and Collaboration Scenario
PEST Analysis
PORTER'S Five Forces
Epidemiology
Company Market Share Analysis

4. Middle East and Asia Pacific Cell and Gene Therapy Market, By Therapy Type, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - Stem Cells
  - T Cells
  - Dendritic Cells
  - NK Cells
Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - Germline Gene Therapy
  - Somatic Gene Therapy

5. Middle East and Asia Pacific Cell and Gene Therapy Market, By Indication, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Musculoskeletal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cardiology & Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Middle East and Asia Pacific Cell and Gene Therapy Market, By Technology, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Lentiviral Vector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Plasmid DNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
AAV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Middle East and Asia Pacific Cell and Gene Therapy Market, By Region, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
Middle East
- Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
- Market Size and Forecast, By Technology, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Asia Pacific
- Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
- Market Size and Forecast, By Technology, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific

8. Competitive Landscape

Competitive Snapshot
- Novartis International AG
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Pfizer, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Sanofi S.A.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Amgen, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Regeneron Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Hoffmann-La Roche AG
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Bluebird Bio, Inc. (Celgene Corporation)
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Gene biotherapeutics
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Sibiono GeneTech Co. Ltd.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Kolon TissueGene, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Horama S.A.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- MeiraGTx Limited
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Gilead Sciences, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Biogen INC.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Organogenesis, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- JCR Pharmaceuticals Co. Ltd
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- uniQure N.V.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- WuxiAppTec
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Lonza
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Immuneel Therapeutics Pvt Ltd
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

9. Section

References
Research Methodology
About us and Sales Contact